Herbas VPB

Print
EN | LT
LT - Geno raiškos reguliavimas, tarpininkaujant nukleazei
EN - NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C12N 15/09 (2006.01)
A61K 38/46 (2006.01)
A61P 7/00 (2006.01)
A61K 35/12 (2015.01)
A61K 35/28 (2015.01)
C07K 14/47 (2006.01)
C12N 9/22 (2006.01)
C12N 15/113 (2010.01)
European patent
(11) Number of the document 3068881
(13) Kind of document T
(96) European patent application number 14861930.7
Date of filing the European patent application 2014-11-13
(97) Date of publication of the European application 2016-09-21
(45) Date of publication and mention of the grant of the patent 2019-02-27
(46) Date of publication of the claims translation 2019-08-12
PCT application
(86) Number PCT/US2014/065473
Date 2014-11-13
PCT application publication
(87) Number WO 2015/073683
Date 2015-05-21
Priority applications
(30) Number Date Country code
201361903823 P 2013-11-13 US
201462042075 P 2014-08-26 US
Inventors
(72)
ORKIN, Stuart H., US
REIK, Andreas, US
URNOV, Fyodor, US
Grantee
(73) Children`s Medical Center Corporation, 55 Shattuck Street, Boston, MA 02115, US
Sangamo Therapeutics, Inc., Point Richmond Tech Center 501 Canal Blvd., Suite A100, Richmond, CA 94804, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Geno raiškos reguliavimas, tarpininkaujant nukleazei
  NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION
Last renewal fee
Payment date Validity (years) Amount
2023-10-18 10 231.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2024-11-13